Incidence and mortality of malignant melanoma in Berlin (West) from 1980 to 1986. 1991

C Garbe, and S Thiess, and F Nürnberger, and G Ehlers, and G Albrecht, and F Lindlar, and J Bertz
Departments of Dermatology, University Medical Center Steglitz, Free University of Berlin, Germany.

Newly diagnosed melanomas were investigated utilizing the histological reports from the 4 Departments of dermatology as well as from 3 Departments of pathology in Berlin (West) during the years 1980-86. The study included 960 melanomas and documented the histological features, age, gender and nationality of the patients involved. 936 patients were Germans (379 males, 557 females), and the mean age-adjusted incidence rate (for the European standard population) was 7.1 cases per 100,000 inhabitants and year for both genders with an increase between 1980-81 and 1985-86 in men from 6.0 to 9.8 and in women from 5.8 to 7.8/100,000 and year. Thus a 49% increase in incidence was observed for both genders combined during a 5-year period. In this study, a preponderance of male incidence rates was observed for the first time in Germany. Interestingly, the age-adjusted incidence rate for the Turkish population, which is the largest foreign population with more than 100,000 inhabitants in Berlin, was only 1.3/100,000 and year. 162 men and 145 women died of melanoma in the time period examined. From 1980-81 to 1985-86, the age-adjusted mortality rate changed from 3.5 to 2.6 for men and from 1.2 to 1.6 for women per 100,000 and year, thus revealing a slight decrease in mortality for both genders combined.

UI MeSH Term Description Entries
D008297 Male Males
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001604 Berlin The capital of Germany.
D012737 Sex Factors Maleness or femaleness as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or effect of a circumstance. It is used with human or animal concepts but should be differentiated from SEX CHARACTERISTICS, anatomical or physiological manifestations of sex, and from SEX DISTRIBUTION, the number of males and females in given circumstances. Factor, Sex,Factors, Sex,Sex Factor

Related Publications

C Garbe, and S Thiess, and F Nürnberger, and G Ehlers, and G Albrecht, and F Lindlar, and J Bertz
November 1990, Clinical and experimental dermatology,
C Garbe, and S Thiess, and F Nürnberger, and G Ehlers, and G Albrecht, and F Lindlar, and J Bertz
December 1986, Zeitschrift fur Hautkrankheiten,
C Garbe, and S Thiess, and F Nürnberger, and G Ehlers, and G Albrecht, and F Lindlar, and J Bertz
December 1998, The British journal of dermatology,
C Garbe, and S Thiess, and F Nürnberger, and G Ehlers, and G Albrecht, and F Lindlar, and J Bertz
January 1988, Berliner Statistik. Monatsschrift,
C Garbe, and S Thiess, and F Nürnberger, and G Ehlers, and G Albrecht, and F Lindlar, and J Bertz
November 1997, BMJ (Clinical research ed.),
C Garbe, and S Thiess, and F Nürnberger, and G Ehlers, and G Albrecht, and F Lindlar, and J Bertz
August 1991, East African medical journal,
C Garbe, and S Thiess, and F Nürnberger, and G Ehlers, and G Albrecht, and F Lindlar, and J Bertz
July 1971, Journal of the National Cancer Institute,
C Garbe, and S Thiess, and F Nürnberger, and G Ehlers, and G Albrecht, and F Lindlar, and J Bertz
January 1990, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
C Garbe, and S Thiess, and F Nürnberger, and G Ehlers, and G Albrecht, and F Lindlar, and J Bertz
March 1999, The British journal of dermatology,
C Garbe, and S Thiess, and F Nürnberger, and G Ehlers, and G Albrecht, and F Lindlar, and J Bertz
January 1993, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology,
Copied contents to your clipboard!